|
|
Introducing FDA approved Xeomin®, a new alternative to
Botox Cosmetic® and Dysport®!
Merz Aesthetics has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN® (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
Xeomin® has been available worldwide since 2005, and is now being launched in the U.S.! It will be made available to most physicians starting in March 2012, but the elite status and extensive experience of DLVSC's physicians has earned us the privilege of getting Xeomin® early - in November 2011!
A special introductory price will be available for a limited time, as supplies last. Xeomin® will be available to patients on a first come basis. We will have only a limited amount of product available between now and March, so schedule your treatment today!
|
|
|
